Ambu ruled out raising capital in August – now it's "due diligence"
One analyst says the Danish medtech company’s goal to lower its gearing would have happened naturally over time.
by ulrich quistgaard, translated by daniel pedersen
In summer of last year, Ambu leadership outright rejected that the company would have a need to raise more capital – now it is planning to issue shares for over DKK 1bn (USD 145m).
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Ambu mulling over capital raise
For subscribers
